SCHEMBL21782079

SCHEMBL21782079

C=C(C)[C@@H](C(=O)N[C@H](C(=O)N(C)[C@@H]([C@@H](C)CC)[C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)Cc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCC(=O)N2CCC(C(=O)Oc3c(F)c(F)c(F)c(F)c3F)CC2)C(C)C)cc1)OC)C(C)C)N(C)C

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
FOLH1 Q04609 3/20 0.44
TTR P02766 2/20 0.41
SSTR2 P30874 2/20 0.35
NECTIN4 Q96NY8 1/20 0.33
AKT1 P31749 2/20 0.32
FAP Q12884 2/20 0.31
CTSD P07339 1/20 0.31
CTSE P14091 1/20 0.31
BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21781792 0.95 CYP3A4 (0.49) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068457 0.93 CYP3A4 (0.50) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21781846 0.91 CYP3A4 (0.51) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068561 0.90 CYP3A4 (0.52) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068099 0.89 CYP3A4 (0.52) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21781922 0.89 CYP3A4 (0.52) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068086 0.89 CYP3A4 (0.52) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21781795 0.89 CYP3A4 (0.49) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21782009 0.88 CYP3A4 (0.51) CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL26270646 0.88 CYP3A4 (0.47) CYP3A4FOLH1TTRSSTR2NECTIN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3617221-A1 CYTOTOXIN AND CONJUGATE, USES OF SAME, AND PREPARATION METHOD THEREFOR Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-03-04 EP disclosed